<unk>  ranked second on the list of drugs most frequently suspected in reported patient deaths compiled for 2019 by the Institute for Safe Medical Practices, with 1320 suspected deaths. A boxed warning was added in the same year with regard to kidney failure, liver failure and gastrointestinal bleeding. It is suspected that the main driver of this spike in suspected deaths relates to the re-analysis of adverse event data by Novartis.
Deferasirox
Brodifacoum
Deferiprone
Fermagate
Dotinurad
Co-codaprin
Disufenton sodium
Gadobenic acid